- Report
- October 2026
- 14 Pages
Global
From €1413EUR$1,500USD£1,177GBP
- Report
- October 2026
- 51 Pages
Global
From €9417EUR$9,995USD£7,840GBP
- Report
- October 2026
Global
From €7066EUR$7,500USD£5,883GBP
- Clinical Trials
- September 2026
- 3158 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- September 2026
- 205 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- September 2026
- 119 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- September 2026
- 42 Pages
Global
From €9417EUR$9,995USD£7,840GBP
- Report
- September 2026
- 35 Pages
Global
From €9417EUR$9,995USD£7,840GBP
- Report
- September 2026
- 96 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Clinical Trials
- August 2026
- 1099 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- August 2026
- 321 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- August 2026
- 191 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- August 2026
- 92 Pages
Global
From €16954EUR$17,995USD£14,116GBP
- Report
- August 2026
- 46 Pages
Global
From €9417EUR$9,995USD£7,840GBP
- Report
- July 2026
- 56 Pages
Global
From €9417EUR$9,995USD£7,840GBP
- Clinical Trials
- July 2026
- 2247 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- July 2026
- 3257 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- July 2026
- 171 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Clinical Trials
- July 2026
- 395 Pages
Global
From €3250EUR$3,450USD£2,706GBP
- Report
- July 2026
- 77 Pages
Global
From €3293EUR$3,495USD£2,742GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more